Home› India› Ministry of Health and Family Welfare› Drug Alert for the month of May,2018...
Date: 2018-06-06 Category: Not Applicable State: Union Government Country: India

Drug Alert for the month of May,2018

Issued by Ministry of Health and Family Welfare · Central Drugs Standard Control Organization

Research with AI Agent Chat with Document Generate Summary Translate Helpful Share Add to Project Create Task

Executive Summary & Key Takeaways

Gazette Notification Overview

  • This gazette notification lists drugs, medical devices, and cosmetics declared as Not of Standard Quality, Spurious, Adulterated, or Misbranded for the month of May 2018.
  • A total of 43 items are listed, detailing the product name, batch number, manufacturing and expiry dates, manufacturer, reason for failure, and the authority that identified the issue along with the location from where it was drawn.

Key Changes

  • 43 drugs, medical devices and cosmetics are declared as substandard, spurious, adulterated or misbranded.
  • Reasons for failure include: Optical Rotation, Bacterial Endotoxins, Disintegration, Related Substances, Clarity of Solution, Dissolution, Assay of Clavulanic Acid, Particulate matter, Description and Particulate matter, Assay and Dissolution of Enalapril Maleate, Weight per sachet and Swelling of Powder, Total aerobic Microbial Count and presences of Salmonella sp., Assay, Extractable volume, Description and Assay of Serratiopeptidase, Assay/Content of Aceclofenac, Physical Parameter, Uniformity of Weight, Description, Assay, Defect in Fabric, Odour, Skewness, Cracks, Double Ends, Sloughing, Threads per DM (Warp & Weft), Weight in g/m2, Length and Foreign Matter, Identification of Valproic Acid, Assay of Sodium Valproate and Valproic Acid, Assay of Chlorhexidine Gluconate, Water, Dissolution, Total Microbial Count, Disintegration Test and the Assay of Vitamin D3, Identification B and the Assay of Calcium Pantothenate, Chromium Chloride calculated as Elemental Chromium, Assay of Methylcobalamin, Assay of Paracetamol.
  • The products were manufactured by various companies located across India, including Gujarat, Delhi, Maharashtra, Madhya Pradesh, Himachal Pradesh, Tamil Nadu, Goa, and West Bengal.
  • The products were tested by CDSCO (Central Drugs Standard Control Organization) and State Drug Control Departments.

Impact Analysis

Impact on Manufacturers

  • Action Item: Review manufacturing processes and quality control procedures to prevent future occurrences of substandard products. Implement corrective and preventive actions (CAPA) to address the root causes of the identified failures.

Impact on Consumers

  • Action Item: Healthcare providers should be informed about the listed products and advised to avoid prescribing or dispensing them. Patients who have used these products should be monitored for any adverse effects.

Impact on Regulatory Bodies

  • Action Item: Strengthen post-market surveillance and testing programs to identify and remove substandard products from the market. Increase collaboration between central and state drug regulators to ensure consistent enforcement of quality standards.

Impact on Supply Chain

  • Action Item: Review and strengthen supply chain management practices to ensure the quality and integrity of pharmaceutical products. Implement traceability systems to track products from manufacturer to consumer.

Key Entities Referenced

CDSCO: Central Drugs Standard Control Organization, the national regulatory body for pharmaceuticals and medical devices in India. State Drug Control Departments: State-level regulatory bodies responsible for enforcing drug regulations within their respective states. Bajaj Healthcare Limited: Manufacturer of Choline Bitartrate, found to be Not of Standard Quality due to Optical Rotation issues. Gopish Pharma: Manufacturer of Gentamicin Sulphate Injection, found to be Not of Standard Quality due to Bacterial Endotoxins. Deep Pharma: Manufacturer of Diclofen – SR (Diclofenac Sodium Tablets I.P.), found to be Not of Standard Quality due to Disintegration issues. Modern Laboratories: Manufacturer of ONDANSETRON (Ondansetron Injection I.P. 2 mg/ml), found to be Not of Standard Quality due to Related Substances issues. M.J. Biopharm Pvt. Ltd.: Manufacturer of CEFTRIAXONE MJ (Ceftriaxone for Injection I.P. 1 g), found to be Not of Standard Quality due to Clarity of Solution issues. Adroit Pharmaceuticals Pvt. Ltd.: Manufacturer of Pantoprazole Sodium Tablets I.P., found to be Not of Standard Quality due to Dissolution issues. Park Pharmaceuticals: Manufacturer of Licomox – 625 Tablets (Amoxycillin and Potassium Clavulanate Tablets I.P.), found to be Not of Standard Quality due to Assay of Clavulanic Acid and Dissolution of Amoxycillin and Clavulanic acid issues. ANG Life Sciences (I) Pvt. Ltd.: Manufacturer of Glanpan For Powder (Pantoprazole for Injection), found to be Not of Standard Quality due to Particulate matter issues. Auraya Healthcare: Manufacturer of Sodium Chloride Injection, found to be Not of Standard Quality. Macin Remedies India Ltd.: Manufacturer of Oxymac (Oxytocin Inj. I.P. 5 IU), found to be Not of Standard Quality due to Description and Particulate matter issues. Surien Pharmaceuticals (P) Ltd.: Manufacturer of Enclard – 5 (Enalapril Maleate Tablets I.P.), found to be Not of Standard Quality due to Assay and Dissolution of Enalapril Maleate issues. Vivimed Labs Limited: Manufacturer of Isphagula Husk, found to be Not of Standard Quality due to Weight per sachet and Swelling of Powder, Total aerobic Microbial Count and presences of Salmonella sp. issues. Toyo Laboratories Pvt. Ltd.: Manufacturer of T-Pant 40 (Pantoprazole Sodium Tablets), found to be Not of Standard Quality due to Assay issues. Micropure Parenterals Pvt. Ltd.: Manufacturer of MERIDECA (Dexamethasone Sodium Phosphate Injection I.P. 20 ml), found to be Not of Standard Quality due to Extractable volume issues. Panacea Biotech Ltd.: Manufacturer of Alphadol (Alfacalcidol Capsules 0.25 mcg), found to be Not of Standard Quality due to Assay issues. Systochem Laboratories Ltd.: Manufacturer of Phytomenadione Injection (Vit – K1), found to be Not of Standard Quality due to Description and Particulate contamination (Visible Particulate) issues. Karnataka Antibiotics & Pharmaceuticals Limited: Manufacturer of Calcium and Colecalciferol Tablets B.P. (500 mg + 250 IU) (Calcium and Vitamin D3 (Colecalciferol) Tablets), found to be Not of Standard Quality due to Assay/Content of Colecalciferol (Vitamin D3) issues. Amree Pharmaceuticals: Manufacturer of Brodagesic SP (Diclofenac Potassium, Paracetamol & Serratiopeptidase Tablets), found to be Not of Standard Quality due to Description and Assay of Serratiopeptidase issues. Panm Biotech Pvt. Ltd.: Manufacturer of ACEONE-SP Tablets (Aceclofenac, Paracetamol & Serratiopeptidase Tablets), found to be Not of Standard Quality due to Assay/Content of Aceclofenac issues. Kwality Pharmaceuticals Ltd.: Manufacturer of S-Amlodipine Tablets I.P., found to be Not of Standard Quality due to Assay issues. Angel Laboratories (P) ltd.: Manufacturer of Bromol Plus Cough Expectorant, found to be Not of Standard Quality due to Physical Parameter issues. Sunrise Remedies Pvt. Ltd: Manufacturer of Cefosun-200 Tablets, found to be Not of Standard Quality due to Dissolution issues. Bengal Chemical & Pharmaceuticals Ltd.: Manufacturer of Paracetamol Tablets I.P., found to be Not of Standard Quality due to Physical Parameter & Uniformity of Weight issues. Nandani Medical Laboratories Pvt. Ltd.: Manufacturer of Diazepam Injection IP, found to be Not of Standard Quality due to Description issues. Seeko Biotics: Manufacturer of Ranitidine Hydrochloride Tablets IP 150mg, found to be Not of Standard Quality due to Assay issues. HAB Pharmaceuticals & Research Ltd.: Manufacturer of Prozol-P (Pantoprazole Tablets IP), found to be Not of Standard Quality due to Dissolution issues. Lesanto Laboratories: Manufacturer of Prohibin (Omeprazole Capsules IP), found to be Not of Standard Quality due to Dissolution issues. Sundaram Surgical: Manufacturer of Rolled (Gauze SCH F II), found to be Not of Standard Quality due to Defect in Fabric, Odour, Skewness, Cracks, Double Ends, Sloughing, Threads per DM (Warp & Weft), Weight in g/m2, Length and Foreign Matter issues. Symbiosis Pharmaceuticals Pvt. Ltd.: Manufacturer of Rabeprazole (EC) and Domperidone (SR) Capsules (OLEZ-DSR CAPSULES), found to be Not of Standard Quality due to Dissolution (Rabeprazole Sodium) (In Acidic medium), (In Buffer Medium), Dissolution (Domperidone Sustained release) issues. Pulse Pharmaceuticals Pvt. Ltd.: Manufacturer of Sodium Valproate Tablets 200 mg (VAT CR 200 TABLETS), found to be Not of Standard Quality due to Identification of Valproic Acid, Assay of Sodium Valproate and Valproic Acid issues. Neptune Life Sciences Pvt. Ltd.: Manufacturer of Chlorhexidine Gluconate, Mouth wash IP (DENTO FRESH MOUTH WASH), found to be Not of Standard Quality due to Assay of Chlorhexidine Gluconate Solution Diluted calculated as Chlorhexidine Gluconate issues. Jackson Laboratories Pvt. Ltd.: Manufacturer of Cefotaxime Sodium Injection BP (CEFOX-125 INJECTION), found to be Not of Standard Quality due to Water issues. Morepen Laboratories Limited: Manufacturer of Clarithromycin Tablets IP 250 mg (KLARIM TABLETS), found to be Not of Standard Quality due to Dissolution (Clarithromycin) issues. Vidhi Cosmetics: Manufacturer of Fuor Lovely Multi Vitam Premium Beauty Cream, found to be Not of Standard Quality due to Total Microbial Count issues. Quixotic Healthcare: Manufacturer of Ondansetron Injection IP (ONDET INJECTION), found to be Not of Standard Quality due to Related Substances issues. Ultra Drug Pvt. Ltd.: Manufacturer of Calcium Citrate, Magnesium, Zinc and Vitamin D3 Tablets (CALIVE TABLETS), found to be Not of Standard Quality due to Disintegration Test and the Assay of Vitamin D3 issues. Ultratech Pharmaceuticals: Manufacturer of Vitamin B-Complex with Minerals Tablets (COMVITA-M TABLETS), found to be Not of Standard Quality due to Identification B and the Assay of Calcium Pantothenate, Chromium Chloride calculated as Elemental Chromium issues. Mas Pharmachem: Manufacturer of Omega 3 Fatty Acid, Methylcobalamin, Calcitriol, Calcium and Folic Acid Softgel Capsules (HI-LIFE CAPSULES), found to be Not of Standard Quality due to Assay of Methylcobalamin issues. ALEXIN Biosciences: Manufacturer of Paracetamol Suspension IP (KIDMOL-250 SUSPENSION), found to be Not of Standard Quality due to Assay of Paracetamol issues. Karnataka Antibiotics & Pharmaceuticals Limited: Manufacturer of Glimepiride Tablets IP 2 MG, found to be Not of Standard Quality due to Dissolution issues. Karnataka Antibiotics & Pharmaceuticals Limited: Manufacturer of Glimepiride Tablets IP 1 MG, found to be Not of Standard Quality due to Dissolution issues.
Official Source Record View Original Source →
See Full Document Text
List of Drugs, Medical Devices and Cosmetics declared as Not of Standard Quality/Spurious/Adulterated/Misbranded, For the Month of MAY, 2018 Sl. Name of Batch No./Date of Reason for Drawn By From No. Drugs/medical Manufacture/Date of failure device/cosmetics Expiry/Manufactured By 1. Choline Bitartrate B. No.: CBP-00711217, Optical Rotation CDSCO, CDL, NF Mfg dt: 12/2017, Zonal Office, Kolkata Exp dt: 11/2022, Ahmedabad. Mfd by: M/s. Bajaj Healthcare Limited (Unit-2), Block No. 588, Savli Karachia Road, At & Post – Gothada, Tal Savli, Distt. Vadodara, Gujarat. 2. Gentamicin B. No.: 355, Bacterial CDSCO, CDL, Sulphate Injection Mfg dt: 02/2017, Endotoxins East Zone Kolkata Exp dt: 01/2019, Kolkata. I.P. – 2 ml Mfd by: M/s. Gopish Pharma, H- 1455, DSIDC, Narela Ind. Park, Narela, Delhi – 110 040. 3. Diclofen – SR B. No.: 656, Disintegration CDSCO, CDL, (Diclofenac Mfg dt: 06/2016, Zonal Office, Kolkata Exp dt: 05/2018, Ahmedabad. Sodium Tablets Mfd by: M/s. Deep Pharma, I.P.) Khedut Sabha Building, Dholka – 382 225, Distt. Ahmedabad, Gujarat, India. 4. ONDANSETRON B. No.: ONI1612, Related CDSCO, CDL, (Ondansetron Mfg dt: 06/2016, Substances Zonal Office, Kolkata Exp dt: 05/2018, Ahmedabad. Injection I.P. 2 Mfd by: M/s. Modern mg/ml) Laboratories, 45-47, Sector D-2, Sanwer Road, Indore (M.P.) – 452 015. 5. CEFTRIAXONE B. No.: T3C441216, Clarity of CDSCO, CDL, MJ (Ceftriaxone Mfg dt: 12/2016, Solution East-Zone, Kolkata Exp dt: 11/2018, Kolkata for Injection I.P. 1 Mfd by: M/s. M.J. Biopharm g) Pvt. Ltd., L-7, MIDC Indl. Area, Taloja, Dist. Raigad, Navi Mumbai – 410 208, Maharashtra. 6. Pantoprazole B. No.: 1709012, Dissolution CDSCO, CDL, Sodium Tablets Mfg dt: 09/2017, East-Zone, Kolkata Exp dt: 02/2019 Kolkata I.P. Mfd by: M/s. Adroit Pharmaceuticals Pvt. Ltd., At.: 46, Garoba Maidan, Nagpur – 440 008.7. Licomox – 625 B. No.: SPH-057, Assay of CDSCO, CDL, Tablets Mfg dt: 02/2017, Clavulanic Acid Sub-Zone, Kolkata (Amoxycillin and Exp dt: 07/2018, and Dissolution Baddi. Potassium Mfd by: M/s. Park of Amoxycillin Clavulanate Pharmaceuticals, Vill. and Clavulanic Tablets I.P.) Kalujhanda, Near Nanakpur, Teh acid Baddi, Distt. Solan (H.P.). 8. Glanpan For Powder Particulate matter CDSCO, CDL, (Pantoprazole for B. No.: A017162D, East-Zone, Kolkata Mfg dt: 09/2017 Kolkata Injection) Exp dt: 08/2019 Mfd by: M/s. ANG Life Sciences (I) Pvt. Ltd., Vill. Kishanpura, P.O. Manpura, Tehsil Nalagarh, Distt. Solan (H.P.) – 174 101 For Sodium Chloride Injection B. No.:NB7G07, Mfg dt: 07/2017, Exp dt: 06/2020, M/s. Auraya Healthcare, Plot No. 80E, EPIP, Phase – I, Jharmajri, Baddi (HP), India 9. Oxymac (Oxytocin B. No.: OT-1642, Description and CDSCO, CDL, Inj. I.P. 5 IU) Mfg dt: 12/2016, Particulate matter Sub-Zone, Kolkata Exp dt: 11/2018, Baddi. Mfd by: M/s. Macin Remedies India Ltd., B-21, Industrial Focal Point, Moga (Pb) – 142 001. 10. Enclard – 5 B. No.: NCA-002, Assay CDSCO, CDL, (Enalapril Maleate Mfg dt: 12/2016, and East-Zone, Kolkata Exp dt: 11/2018, Dissolution of Kolkata. Tablets I.P.) Mfd by: M/s. Surien Enalapril Maleate Pharmaceuticals (P) Ltd., 108, Chekkady Street, Kovur, Chennai – 600 128. 11. Isphagula Husk B. No.: IH.6064, Weight per sachet CDSCO, CDL, Mfg dt: 08/2016, and Swelling of South-Zone, Kolkata Exp dt: 07/2018, Powder, Total Chennai. Mfd by: M/s. Vivimed Labs aerobic Microbial Limited, Plot No. 41, 44A & Count and 44B, Anrich Industrial Estate, presences of IDA, Bollaram, Medak Dist. Salmonella sp. A.P. – 502 325. 12. T-Pant 40 B. No.: 64/E4, Assay CDSCO, CDL, (Pantoprazole Mfg dt: 10/2016, Sub-Zone, Kolkata Exp dt: 09/2018, Goa. Sodium Tablets) Mfd by: M/s. Toyo Laboratories Pvt. Ltd., Ponda, Goa – 403 401, At.: 99, C & D, KIADBIndustrial Estate, Honaga, Belgaum. 13. MERIDECA B. No.: WMI16250, Extractable CDSCO, CDL, (Dexamethasone Mfg dt: 12/2016, volume (HQ), Kolkata Exp dt: 11/2018, New Delhi. Sodium Phosphate Mfd by: M/s. Micropure Injection I.P. 20 Parenterals Pvt. Ltd., 136, ml) Neharoli, Wada, Palghar – 421 312. 14. Alphadol B. No.: 30136521, Assay CDSCO, CDL, (Alfacalcidol Mfg dt: 08/2016, East-Zone, Kolkata Exp dt: 07/2018, Kolkata. Capsules 0.25 mcg) Mfd by: M/s. Panacea Biotech Ltd., Malpur, Baddi, Dist. Solan, H.P. – 173 205. 15. Phytomenadione B. No.: KPM-1602, Description and CDSCO, CDL, Injection (Vit – Mfg dt: 08/2016, Particulate Sub-Zone, Kolkata Exp dt: 07/2018, contamination Bangalore. K1) Mfd by: M/s. Systochem (Visible Laboratories Ltd., B-75, Roop Particulate) Nagar Indl. Area, Loni – 201 102. 16. Calcium and B. No.: CUTT-59, Assay/Content of CDSCO, CDL, Colecalciferol Mfg dt: 09/2016, Colecalciferol Sub-Zone, Kolkata Exp dt: 08/2018, Baddi. Tablets B.P. (500 (Vitamin D ) 3 Mfd by: M/s. Karnataka mg + 250 IU) Antibiotics & Pharmaceuticals (Calcium and Limited, at, 11, Western Vitamin D 3 Extension Area, Faridabad – 121 (Colecalciferol) 001. Tablets) 17. Brodagesic SP B. No.: KN-107, Description and CDSCO, CDL, (Diclofenac Mfg dt: 05/2017, Assay of (HQ), Kolkata Potassium, Exp dt: 04/2019, Serratiopeptidase New Delhi. Paracetamol & Mfd by: M/s. Amree Serratiopeptidase Pharmaceuticals, Plot No. 1, Tablets) Street 10, Kaithal Road, Karnal – 132 001. 18. ACEONE-SP B. No.: PT-9714, Assay/Content of CDSCO, CDL, Tablets Mfg dt: 03/2017, Aceclofenac Sub-Zone, Kolkata (Aceclofenac, Exp dt: 02/2019, Goa. Paracetamol & Mfd by: M/s. Panm Biotech Pvt. Serratiopeptidase Ltd., Village Moginand, Nahan Tablets) Road, Kala-Amb, Distt. Sirmour (H.P.) – 173 030.19. S-Amlodipine B. No.: T-5285, Assay Drugs Control RDTL, Tablets I.P. Mfg dt: 02/2017, Department, Guwahati Exp dt: 01/2019, Assam Mfd by: M/s. Kwality Pharmaceuticals Ltd., Nag Kalan, Majitha Road, Amritsar 20. Bromol Plus B. No.: BT-197, Physical Drugs Control RDTL, Cough Expectorant Mfg dt: 11/2017, Parameter Department, Guwahati Exp dt: 10/2019, Meghalaya Mfd by: M/s. Angel Laboratories (P) ltd., Dakshin Jagaddal, Kolkata-51 21. Bromol Plus B. No.: BT-199, Physical Drugs Control RDTL, Cough Expectorant Mfg dt: 11/2017, Parameter Department, Guwahati Exp dt: 10/2019, Meghalaya Mfd by: M/s. Angel Laboratories (P) ltd., Dakshin Jagaddal, Kolkata-51 22. Cefosun-200 B. No.: B-1364, Dissolution Drugs Control RDTL, Tablets Mfg dt: 09/2017, Department, Guwahati Exp dt: 08/2019, Kolkata Mfd by: M/s. Sunrise Remedies Pvt. Ltd, Block No. 2244, Opp. Shah Steel, Santej, Ta: Kalol, Gandhinagar 23. Paracetamol B. No.: 5481007, Physical Drugs Control RDTL, Tablets I.P. Mfg dt: 09/2015, Parameter & Department, Guwahati Exp dt: 08/2018, Assam Uniformity of Mfd by: M/s. Bengal Chemical Weight & Pharmaceuticals Ltd., 164, Maniktala Main Road, Kolkata- 700054 24. Paracetamol B. No.: 5481005, Physical Drugs Control RDTL, Tablets I.P. Mfg dt: 09/2015, Parameter & Department, Guwahati Exp dt: 08/2018, Assam Uniformity of Mfd by: M/s. Bengal Chemical Weight & Pharmaceuticals Ltd., 164, Maniktala Main Road, Kolkata- 700054 25. Paracetamol B. No.: 5481004, Physical Drugs Control RDTL, Tablets I.P. Mfg dt: 08/2015, Parameter Department, Guwahati Exp dt: 07/2018, & Assam Mfd by: M/s. Bengal Chemical Uniformity of & Pharmaceuticals Ltd., 164, Weight Maniktala Main Road, Kolkata- 700054 26. Diazepam Injection B. No.: DZ1704, Description CDSCO, CDTL, IP Mfg dt: 05/2017, South-Zone, Chennai Exp dt: 04/2019, Chennai Mfd by: M/s. Nandani Medical Laboratories Pvt. Ltd., 221/5,Bicholi Hapsi, Kanadia Road, Indore. 27. Ranitidine B. No.: 1027, Assay CDSCO, CDTL, Hydrochloride Mfg dt: 02/2018, Hyderabad Chennai Exp dt: 01/2020, Zonal office Tablets IP 150mg Mfd by: M/s. Seeko Biotics Krishna Nagar-522502 28. Prozol-P B. No.: 27-72, Dissolution CDSCO, CDTL, (Pantoprazole Mfg dt: 02/2017, West-Zone, Mumbai Exp dt: 07/2019, Mumbai Tablets IP) Mfd by: M/s. HAB Pharmaceuticals & Research Ltd., 10, Pharmacity, SIDCUL, Selaqui, Dehradun-248197. 29. Prohibin B. No.: 7005, Dissolution CDSCO, CDTL, (Omeprazole Mfg dt: 05/2017, West-Zone, Mumbai Exp dt: 04/2019, Mumbai Capsules IP) Mfd by: M/s. Lesanto Laboratories, Plot No. 9, 10, 11 & 20, Survey No.53, Palghar- 401404. 30. Rolled (Gauze B. No.: 86, Defect in Fabric, CDSCO, CDTL, SCH F II) Mfg dt: 03/2016, Odour, Skewness, West-Zone, Mumbai Exp dt: 03/2019, Cracks, Double Mumbai Mfd by: M/s. Sundaram Ends, Sloughing, Surgical, Chatrapatti-626102. Threads per DM (Warp & Weft), Weight in g/m2, Length and Foreign Matter 31. Rabeprazole (EC) B. No.: SOC-587, Dissolution CDSCO, RDTL, and Domperidone Mfg dt: 12/2017, (Rabeprazole Sub-Zone, Chandigarh Exp dt: 11/2019, Sodium) (In Baddi. (SR) Capsules Mfd by: M/s. Symbiosis Acidic medium), (OLEZ-DSR Pharmaceuticals Pvt. Ltd., (Unit- (In Buffer CAPSULES) III) Plant at: Trilokpur Road, Medium), Kala Amb-173030 (HP). Dissolution (Domperidone Sustained release) 32. Sodium Valproate B. No.: VCR1197D, Identification of CDSCO, RDTL, Tablets 200 mg Mfg dt: 06/2017, Valproic Acid, North-Zone, Chandigarh Exp dt: 05/2019, Ghaziabad (VAT CR 200 Assay of Sodium Mfd by: M/s. Pulse TABLETS) Valproate and Pharmaceuticals Pvt. Ltd., Valproic Acid. Khasra No.400, 407, 409, Karondi, Roorkee, Uttarakhand - 247667.33. Chlorhexidine B. No.: NLE458, Assay of CDSCO, RDTL, Gluconate, Mouth Mfg dt: 04/2017, Chlorhexidine Sub-Zone, Chandigarh wash IP (DENTO Exp dt: 03/2019, Gluconate Baddi FRESH MOUTH Mfd by: M/s. Neptune Life Solution Diluted WASH) Sciences Pvt. Ltd., 100-B, EPIP calculated as Phase-II, Thana, Baddi-173205 Chlorhexidine (H.P.) Gluconate 34. Cefotaxime B. No.: I-11820, Water Drug Control RDTL, Sodium Injection Mfg dt: 07/2016, Department, Chandigarh BP (CEFOX-125 Exp dt: 06/2018, H.P. INJECTION) Mfd by: M/s. Jackson Laboratories Pvt. Ltd., Bye Pass, Majitha Road, Amritsar-143001. 35. Clarithromycin B. No.: C-70357, Dissolution CDSCO, RDTL, Tablets IP 250 mg Mfg dt: 05/2017, (Clarithromycin) Sub-Zone, Chandigarh Exp dt: 04/2019, Baddi (KLARIM Mfd by: M/s. Morepen TABLETS) Laboratories Limited, Unit-V, Plot No.12-C, Sector-2, Parwanoo, Distt. Solan (H.P.)-173220 36. Fuor Lovely Multi B. No.: 01, Total Microbial Drugs Control RDTL, Vitam Premium Mfg dt: 01/2018, Count Department, Chandigarh Beauty Cream Exp dt: 12/2021, Delhi. Mfd by: M/s. Vidhi Cosmetics, Delhi 37. Ondansetron B. No.: Ql-2432, Related CDSCO, RDTL, Injection IP Mfg dt: 07/2016, Substances Sub-Zone, Chandigarh Exp dt: 06/2018, Baddi (ONDET Mfd by: M/s. Quixotic INJECTION) Healthcare, Unit-II, Vill. Kalujhanda, Baddi, Distt.Solan (H.P.) 38. Calcium Citrate, B. No.: UDT-7595B, Disintegration CDSCO, RDTL, Magnesium, Zinc Mfg dt: 09/2017, Test and the Sub-Zone, Chandigarh and Vitamin D3 Exp dt: 08/2019, Assay of Vitamin Baddi Tablets (CALIVE Mfd by: M/s. Ultra Drug Pvt. D3 TABLETS) Ltd., Manpura, Nalagarh, Distt. Solan (H.P.) 39. Vitamin B- B. No.: ULT-1139, Identification B CDSCO, RDTL, Complex with Mfg dt: 01/2018, and the Assay of Sub-Zone, Chandigarh Exp dt: 06/2019, Calcium Baddi Minerals Tablets Mfd by: M/s. Ultratech Pantothenate, (COMVITA-M Pharmaceuticals, Vill. Tipra, Chromium TABLETS) P.O.Barotiwala, Distt.Solan Chloride (H.P.) calculated as Elemental Chromium40. Omega 3 Fatty B. No.: D1608128, Assay CDSCO, RDTL, Acid, Mfg dt: 08/2016, of Sub-Zone, Chandigarh Methylcobalamin, Exp dt: 07/2018, Methylcobalamin Baddi Calcitriol, Calcium Mfd by: M/s. Mas Pharmachem, and Folic Acid Village Dattowal, Manali Road, Softgel Capsules Tehsil Nalagarh, Distt.Solan (HI-LIFE (H.P.) CAPSULES) 41. Paracetamol B. No.: ABSL17-265, Assay Sirmour RDTL, Suspension IP Mfg dt: 12/2017, of (Distt), H.P. Chandigarh Exp dt: 11/2019, Paracetamol (KIDMOL-250 Mfd by: M/s. ALEXIN SUSPENSION) Biosciences, Vill.-Barotiwala, Plot No.151/196, Paonta Sahib, Distt.-Sirmour, Himachal Pradesh-173025 42. Glimepiride B. No.: GL2G37, Dissolution CDSCO, RDTL, Tablets IP 2 MG Mfg dt: 02/2017, North-Zone, Chandigarh Exp dt: 01/2020, Ghaziabad Mfd by: M/s. Karnataka Antibiotics & Pharmaceuticals Limited, L-43, Verna Indl. Estate, Verna, Salcete, Goa- 403722. 43. Glimepiride B. No.: GL1G17, Dissolution CDSCO, RDTL, Tablets IP 1 MG Mfg dt: 02/2017, North-Zone, Chandigarh Exp dt: 01/2020, Ghaziabad Mfd by: M/s. Karnataka Antibiotics & Pharmaceuticals Limited, L-43, Verna Indl. Estate, Verna, Salcete, Goa- 403722.

Continue your research

Related Documents from Ministry of Health and Family Welfare